Kidney Diseases: all 3,843 studies
Page 36 of 39. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Kidney Disease in Liver Transplant RecipientsWithdrawnNCT00585429
- Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDPStatus unknownNCT00584350Phase 4
- Effect of Parenteral Iron Therapy on Inflammatory Response and Oxidative Stress Chronic HemodialysisCompletedNCT00583973
- African American Study of Kidney Disease and Hypertension ABPM Pilot StudyCompletedNCT00582777Phase 2/3
- Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney DiseaseTerminatedNCT00581269Phase 2
- A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney TransplantTerminatedNCT00576602Phase 4
- More Frequent Dialysis (>3 Treatments Per Week)CompletedNCT00575497Not applicable
- Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal FailureTerminatedNCT00575419Phase 1
- Improved Delivery of Cardiovascular Care Through Outreach FacilitationCompletedNCT00574808Phase 1
- Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal DiseaseWithdrawnNCT00573547Phase 4
- Optimalization of Nephroprotection Using N-AcetylcysteineCompletedNCT00572663Not applicable
- Optimalization of Nephroprotection Using Atorvastatin (Sortis)CompletedNCT00572312Not applicable
- Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain StudyCompletedNCT00571909Not applicable
- Value of Rituximab in Humoral Chronic Rejection After Renal TransplantationTerminatedNCT00568477Phase 2
- Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney DiseaseCompletedNCT00566670
- Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3Status unknownNCT00565396Not applicable
- Benfotiamine in Diabetic NephropathyCompletedNCT00565318Phase 4
- A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease PatientsCompletedNCT00563355Not applicable
- Adiponectin in Obese Women With T2DN and Effects by RAS BlockerCompletedNCT00561704Not applicable
- Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis PatientsCompletedNCT00561093Phase 3
- Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage DisequilibriumCompletedNCT00559767
- Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic NephropathyCompletedNCT00556465Phase 2/3
- Long-Term Effect of Soy Consumption on Cardio-Renal Indices and CRP in Type 2diabetes With NephropathyCompletedNCT00555490Phase 1
- Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA NephropathyCompletedNCT00554502Phase 3
- Native Kidney Denervation in Patients With End Stage Renal DiseaseCompletedNCT00551304Phase 1
- Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A NephropathyCompletedNCT00549692Phase 3
- Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft FunctionStatus unknownNCT00541814Phase 4
- Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium BicarbonateCompletedNCT00540904Phase 2
- A Study of Iron Oligosaccharide in Chronic Kidney Disease PatientsCompletedNCT00536666Phase 3
- Vitamin D 2 to Dialysis PatientsTerminatedNCT00535158
- Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant SurvivalCompletedNCT00531921
- Sodium Bicarbonate in Preventing Contrast Induced NephropathyCompletedNCT00531765Not applicable
- CBT to Treat Depression in Renal PatientsStatus unknownNCT00530296Not applicable
- Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With HyperphosphatemiaCompletedNCT00530114Phase 2
- NESP Pediatric StudyCompletedNCT00527137Phase 3
- Erythropoietin Resistance in Anemia of Chronic Kidney DiseaseCompletedNCT00526747
- Effects of Mesna on Homocysteine in Kidney FailureCompletedNCT00524199Phase 2
- To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)CompletedNCT00518362Not applicable
- To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)CompletedNCT00518219Phase 4
- Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?Status unknownNCT00516880Not applicable
- Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN)CompletedNCT00514150Phase 3
- Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTNCompletedNCT00513825Phase 2
- Effects of Oral Cholecalciferol (Vitamin D3) on Bone Health, Neuromuscular Function, and Quality of Life in Adults With Chronic Kidney DiseaseCompletedNCT00511225Not applicable
- Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney DiseaseCompletedNCT00506506Phase 3
- Safe Renal Function In Long Term Heart Transplanted PatientsStatus unknownNCT00505102Phase 4
- A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisCompletedNCT00505037Phase 2
- Vitamin D and Carboxy PTH Fragments in Coronary CalcificationWithdrawnNCT00502268Phase 4
- Fanconi Syndrome Due to ARVs in HIV-Infected PersonsCompletedNCT00499187
- Spironolactone for Reducing Proteinuria in Diabetic NephropathyCompletedNCT00498537Not applicable
- The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney DiseaseCompletedNCT00498342Not applicable
- A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal DiseaseTerminatedNCT00498212Phase 2
- Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care ProgramStatus unknownNCT00498147
- Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based StudyStatus unknownNCT00497666
- COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasTCompletedNCT00497328Phase 2/3
- A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.TerminatedNCT00495365Phase 4
- The Use of Sodium Bicarbonate in the Prevention of Contrast Induced NephropathyTerminatedNCT00494637Not applicable
- Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced NephropathyCompletedNCT00492518Phase 4
- Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)CompletedNCT00490737Phase 1
- Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis PatientsCompletedNCT00485706Not applicable
- Pharmacokinetic Study of Fondaparinux in Outpatients With Renal DysfunctionWithdrawnNCT00483600Not applicable
- Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus ErythematosusTerminatedNCT00479622Phase 1
- Follow-up Study to Previous CARE TrialCompletedNCT00479024
- Loop Diuretics in Chronic Kidney DiseaseCompletedNCT00478543Phase 4
- Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) TrialTerminatedNCT00476619Phase 4
- Prevention of Contrast Induced Nephropathy With Sodium BicarbonateCompletedNCT00472563Phase 2/3
- A Study Of Oral Paricalcitol To Treat Proteinuric Renal DiseaseWithdrawnNCT00469625Not applicable
- Treatment of Secondary Hyperparathyroidism in the Uremic PatientTerminatedNCT00469599Not applicable
- Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization PatientsCompletedNCT00467311
- Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic NephropathyCompletedNCT00464880Phase 1/2
- Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt NephropathyCompletedNCT00464776Phase 1/2
- Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-AcetylcysteinCompletedNCT00463749Phase 3
- Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong KongTerminatedNCT00462202Phase 3
- Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum CarbonateCompletedNCT00458289Phase 1
- Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney DiseaseCompletedNCT00456859Phase 4
- Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5TerminatedNCT00452478Phase 4
- Rosiglitazone and Insulin Resistance in Renally Impaired PatientsTerminatedNCT00452166Phase 3
- A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With HyperphosphatemiaTerminatedNCT00451295Phase 3
- Effect of Low Protein Diet in Preventing the Progression of Diabetic NephropathyTerminatedNCT00448526Not applicable
- Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) PatientsStatus unknownNCT00448071Phase 2
- Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based ImmunosuppresionStatus unknownNCT00443508Phase 4
- A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.CompletedNCT00442793Phase 3
- Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial FunctionSuspendedNCT00442299Phase 1/2
- The Role of P-cresol and Related Protein Fermentation Metabolites in Chronic Kidney Disease PatientsCompletedNCT00441623
- Effects of N-acetylcysteine on Muscle Fatigue in HemodialysisCompletedNCT00440869Phase 1
- Cross-Over Study of Sevelamer Hydrochloride and Sevelamer CarbonateCompletedNCT00440648Phase 2
- Relation Between Polymorphism in Genes Related to Kidney Disease and Renal Manifistations in Fabry DiseaseCompletedNCT00437944
- A Study of NeoRecormon in Patients With Chronic Kidney Disease.CompletedNCT00437723Phase 4
- Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving DialysisCompletedNCT00436995Phase 3
- Diabetic Patients With End-Stage Renal DiseaseCompletedNCT00435786
- The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis PatientsTerminatedNCT00433342Phase 1
- The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal DialysisCompletedNCT00433264
- Effects of Omega 3 in Hemodialysis PatientsCompletedNCT00431899Not applicable
- Effect of Hemodialysis on Toe Pressure- and Finger Pressure and Skin Autofluorescence in Hemodialysis PatientsCompletedNCT00431314
- A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA NephropathyCompletedNCT00426348Phase 4
- Rituximab in Membranous NephropathyCompletedNCT00425217Phase 2/3
- Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced NephropathyStatus unknownNCT00424320Phase 3
- Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes MellitusCompletedNCT00419835Phase 4
- Protein-bound Uremic Retention Solutes and Long Nocturnal Hemodialysis: a Longitudinal AnalysisCompletedNCT00417339
- Ergocalciferol in Chronic Kidney DiseaseCompletedNCT00411294
- Comparison of Post-dilution On-line Hemodiafiltration and HemodialysisCompletedNCT00411177Phase 4